ALKERMES reported 40.05M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Amgen AMGN:US $ 1256M 147M
Biogen BIIB:US $ 434.8M 36.1M
Bluebird Bio BLUE:US $ 24.86M 3.48M
Bristol Myers Squibb BMY:US $ 2882M 62M
Coherus Biosciences CHRS:US $ 17.49M 3.61M
Eli Lilly And LLY:US $ 1659.3M 226M
Heron Therapeutics HRTX:US $ 13.8M 5.58M
Horizon Pharma HZNP:US $ 18.54M 48.48M
Intra Cellular Therapies ITCI:US $ 10.75M 0.9M
IONIS PHARMACEUT IONS:US $ 10.35M 5.77M
JAZZ PHA JAZZ:US $ 74.16M 0.82M
Marinus Pharmaceuticals MRNS:US $ 3.3M 1.37M
Minerva Neurosciences NERV:US $ 1.52M 0.07M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Otsuka Holdings 4578:JP Y 180193M 25652M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Revance Therapeutics RVNC:US $ 13.27M 3.25M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M